Intravenous Immunoglobulin Market
According to Intent Market Research, the Intravenous Immunoglobulin Market is expected to grow from USD 12.2 Billion in 2024-e at a CAGR of 8.6% to touch USD 20.1 Billion by 2030. The Intravenous Immunoglobulin Market is dominated by key players such as CSL Behring, Grifols, S.A., Takeda Pharmaceutical Company Limited, Kedrion Biopharma, Bio Products Laboratory (BPL), and Octapharma AG.